Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:10:25.329Z.
Calculation as of: 2026-10-06T19:10:25.329Z.
Quote observation: 2026-10-06T19:10:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f1b69e3b66f27443032d61e4b8b82fea4bf8ea9e73a5af38069dd33813f2151d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2020-11-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
11.52x
EV/EBITDA RATIO AVG 3Y
8.68x
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$256.86M
EV/EBITDA Ratio
474.98x
TTM Avg
197.45x
3Y Avg
157.93x
5Y Avg
101.85x
Market Cap
$261.97M
EV/EBITDA Ratio
N/A
TTM Avg
2.41x
3Y Avg
3817.71x
5Y Avg
2177.76x
Market Cap
$262.00M
EV/EBITDA Ratio
N/A
TTM Avg
128764.90x
3Y Avg
128764.90x
5Y Avg
128764.90x
Market Cap
$263.68M
EV/EBITDA Ratio
N/A
TTM Avg
10.21x
3Y Avg
10.21x
5Y Avg
10.68x
Market Cap
$263.83M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.16M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AC Immune S.A. (ACIU) | $258.00M | N/A | 11.52x | 8.68x | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.86M | 474.98x | 197.45x | 157.93x | 101.85x |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.74M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $261.97M | N/A | 2.41x | 3817.71x | 2177.76x |
| Palisade Bio, Inc. (PALI)vs › | $262.00M | N/A | 128764.90x | 128764.90x | 128764.90x |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.68M | N/A | 10.21x | 10.21x | 10.68x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $263.83M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.16M | N/A | N/A | N/A | N/A |
| Upstream Bio, Inc. (UPB)vs › | $250.33M | N/A | N/A | N/A | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $265.98M | N/A | 879.29x | 879.29x | 879.29x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2020-11-13 | 20.24x |
| 2020-11-12 | 20.56x |
| 2020-11-11 | 20.32x |
| 2020-11-10 | 18.98x |
| 2020-11-09 | 19.85x |
| 2020-11-06 | 17.88x |
| 2020-11-05 | 23.08x |
| 2020-11-04 | 23.55x |
| 2020-11-03 | 17.25x |
| 2020-11-02 | 15.83x |
| 2020-10-30 | 17.72x |
| 2020-10-29 | 17.25x |
| 2020-10-28 | 16.62x |
| 2020-10-27 | 18.67x |
| 2020-10-26 | 17.96x |
| 2020-10-23 | 19.06x |
| 2020-10-22 | 17.33x |
| 2020-10-21 | 14.96x |
| 2020-10-20 | 16.38x |
| 2020-10-19 | 17.33x |
| 2020-10-16 | 18.19x |
| 2020-10-15 | 17.72x |
| 2020-10-14 | 18.82x |
| 2020-10-13 | 19.06x |
| 2020-10-12 | 19.30x |
| 2020-10-09 | 20.16x |
| 2020-10-08 | 19.37x |
| 2020-10-07 | 18.98x |
| 2020-10-06 | 18.67x |
| 2020-10-05 | 19.30x |
| 2020-10-02 | 17.96x |
| 2020-10-01 | 17.96x |
| 2020-09-30 | 18.19x |
| 2020-09-29 | 17.64x |
| 2020-09-28 | 17.40x |
| 2020-09-25 | 17.48x |
| 2020-09-24 | 17.96x |
| 2020-09-23 | 17.56x |
| 2020-09-22 | 48.45x |
| 2020-09-21 | 49.79x |
| 2020-09-18 | 50.50x |
| 2020-09-17 | 50.26x |
| 2020-09-16 | 49.39x |
| 2020-09-15 | 51.13x |
| 2020-09-14 | 49.00x |
| 2020-09-11 | 41.12x |
| 2020-09-10 | 40.88x |
| 2020-09-09 | 41.83x |
| 2020-09-08 | 39.23x |
| 2020-09-04 | 37.18x |
| 2020-09-03 | 40.49x |
| 2020-09-02 | 40.80x |
| 2020-09-01 | 40.73x |
| 2020-08-31 | 40.88x |
| 2020-08-28 | 38.52x |
| 2020-08-27 | 38.99x |
| 2020-08-26 | 39.15x |
| 2020-08-25 | 40.02x |
| 2020-08-24 | 38.99x |
| 2020-08-21 | 40.33x |
| 2020-08-20 | 35.84x |
| 2020-08-19 | 34.50x |
| 2020-08-18 | 34.90x |
| 2020-08-17 | 35.60x |
| 2020-08-14 | 33.79x |
| 2020-08-13 | 34.58x |
| 2020-08-12 | 32.30x |
| 2020-08-11 | 32.06x |
| 2020-08-10 | 32.53x |
| 2020-08-07 | 32.69x |
| 2020-08-06 | 31.74x |
| 2020-05-04 | 7.49x |
| 2020-05-01 | 6.45x |
| 2020-04-30 | 6.91x |
| 2020-04-29 | 7.29x |
| 2020-04-28 | 7.05x |
| 2020-04-27 | 7.90x |
| 2020-04-24 | 8.15x |
| 2020-04-23 | 7.71x |
| 2020-04-22 | 7.57x |
| 2020-04-21 | 7.65x |
| 2020-04-20 | 7.71x |
| 2020-04-17 | 8.07x |
| 2020-04-16 | 7.74x |
| 2020-04-15 | 7.11x |
| 2020-04-14 | 7.54x |
| 2020-04-13 | 7.03x |
| 2020-04-09 | 6.70x |
| 2020-04-08 | 6.73x |
| 2020-04-07 | 6.43x |
| 2020-04-06 | 7.11x |
| 2020-04-03 | 7.54x |
| 2020-04-02 | 7.65x |
| 2020-04-01 | 6.97x |
| 2020-03-31 | 6.59x |
| 2020-03-30 | 6.33x |
| 2020-03-27 | 4.96x |
| 2020-03-26 | 5.38x |
| 2020-03-25 | 4.56x |
| 2020-03-24 | 4.17x |
| 2020-03-23 | 3.56x |
| 2020-03-20 | 2.64x |
| 2020-03-19 | 2.55x |
| 2020-03-18 | 1.92x |
| 2020-03-17 | 2.64x |
| 2020-03-16 | 1.93x |
| 2020-03-13 | 2.54x |
| 2020-03-12 | 2.91x |
| 2020-03-11 | 3.72x |
| 2020-03-10 | 4.63x |
| 2020-03-09 | 4.37x |
| 2020-03-06 | 5.83x |
| 2020-03-05 | 6.37x |
| 2020-03-04 | 6.25x |
| 2020-03-03 | 5.75x |
| 2020-03-02 | 5.87x |
| 2020-02-28 | 5.71x |
| 2020-02-27 | 6.03x |
| 2020-02-26 | 6.35x |
| 2020-02-25 | 6.32x |
| 2020-02-24 | 7.15x |
| 2020-02-21 | 7.93x |
| 2020-02-20 | 7.92x |
| 2020-02-19 | 8.15x |
| 2020-02-18 | 7.83x |
| 2020-02-14 | 8.09x |
| 2020-02-13 | 7.99x |
| 2020-02-12 | 8.28x |
| 2020-02-11 | 8.25x |
| 2020-02-10 | 8.74x |
| 2020-02-07 | 9.49x |
| 2020-02-06 | 9.58x |
| 2020-02-05 | 9.61x |
| 2020-02-04 | 8.97x |
| 2020-02-03 | 9.69x |
| 2020-01-31 | 9.20x |
| 2020-01-30 | 9.04x |
| 2020-01-29 | 8.61x |
| 2020-01-28 | 8.49x |
| 2020-01-27 | 8.36x |
| 2020-01-24 | 8.26x |
| 2020-01-23 | 9.14x |
| 2020-01-22 | 9.72x |
| 2020-01-21 | 9.43x |
| 2020-01-17 | 9.07x |
| 2020-01-16 | 9.81x |
| 2020-01-15 | 10.07x |
| 2020-01-14 | 10.01x |
| 2020-01-13 | 9.36x |
| 2020-01-10 | 9.22x |
| 2020-01-09 | 9.40x |
| 2020-01-08 | 10.02x |
| 2020-01-07 | 9.37x |
| 2020-01-06 | 8.77x |
| 2020-01-03 | 8.32x |
| 2020-01-02 | 8.29x |
| 2019-12-31 | 8.09x |
| 2019-12-30 | 7.63x |
| 2019-12-27 | 7.90x |
| 2019-12-26 | 7.77x |
| 2019-12-24 | 7.67x |
| 2019-12-23 | 7.63x |
| 2019-12-20 | 7.51x |
| 2019-12-19 | 7.56x |
| 2019-12-18 | 7.37x |
| 2019-12-17 | 7.02x |
| 2019-12-16 | 7.64x |
| 2019-12-13 | 8.12x |
| 2019-12-12 | 8.39x |
| 2019-12-11 | 8.11x |
| 2019-12-10 | 7.86x |
| 2019-12-09 | 8.31x |
| 2019-12-06 | 8.47x |
| 2019-12-05 | 7.62x |
| 2019-12-04 | 6.97x |
| 2019-12-03 | 7.23x |
| 2019-12-02 | 7.12x |
| 2019-11-29 | 7.34x |
| 2019-11-27 | 8.00x |
| 2019-11-26 | 7.98x |
| 2019-11-25 | 7.79x |
| 2019-11-22 | 7.38x |
| 2019-11-21 | 6.53x |
| 2019-11-20 | 7.07x |
| 2019-11-19 | 6.56x |
| 2019-11-18 | 5.97x |
| 2019-11-15 | 5.84x |
| 2019-11-14 | 5.71x |
| 2019-11-13 | 5.22x |
| 2019-11-12 | 3.88x |
| 2019-11-11 | 3.97x |
| 2019-11-08 | 3.92x |
| 2019-11-07 | 3.81x |
| 2019-11-06 | 3.64x |
| 2019-11-05 | 3.59x |
| 2019-11-04 | 3.59x |
| 2019-11-01 | 3.45x |
| 2019-10-31 | 3.84x |
| 2019-10-30 | 4.02x |
| 2019-10-29 | 4.02x |
| 2019-10-28 | 4.11x |
| 2019-10-25 | 3.81x |
| 2019-10-24 | 3.59x |
| 2019-10-23 | 3.40x |
| 2019-10-22 | 3.65x |
| 2019-10-21 | 3.30x |
| 2019-10-18 | 2.71x |
| 2019-10-17 | 2.94x |
| 2019-10-16 | 2.80x |
| 2019-10-15 | 2.89x |
| 2019-10-14 | 2.96x |
| 2019-10-11 | 2.83x |
| 2019-10-10 | 2.77x |
| 2019-10-09 | 2.38x |
| 2019-10-08 | 2.70x |
| 2019-10-07 | 3.04x |
| 2019-10-04 | 3.02x |
| 2019-10-03 | 2.94x |
| 2019-10-02 | 2.91x |
| 2019-10-01 | 2.65x |
| 2019-09-30 | 7.30x |
| 2019-09-27 | 7.26x |
| 2019-09-26 | 6.75x |
| 2019-09-25 | 7.98x |
| 2019-09-24 | 7.88x |
| 2019-09-23 | 8.56x |
| 2019-09-20 | 8.89x |
| 2019-09-19 | 8.78x |
| 2019-09-18 | 8.20x |
| 2019-09-17 | 8.74x |
| 2019-09-16 | 8.96x |
| 2019-09-13 | 7.66x |
| 2019-09-12 | 8.38x |
| 2019-09-11 | 8.56x |
| 2019-09-10 | 8.60x |
| 2019-09-09 | 8.53x |
| 2019-09-06 | 7.84x |
| 2019-09-05 | 7.95x |
| 2019-09-04 | 7.44x |
| 2019-09-03 | 7.26x |
| 2019-08-30 | 8.27x |
| 2019-08-29 | 7.98x |
| 2019-08-28 | 8.20x |
| 2019-08-27 | 7.44x |
| 2019-08-26 | 8.31x |
| 2019-08-23 | 8.60x |
| 2019-08-22 | 9.58x |
| 2019-08-21 | 9.79x |
| 2019-08-20 | 9.83x |
| 2019-08-19 | 10.12x |
| 2019-08-16 | 8.85x |
| 2019-08-15 | 7.98x |
| 2019-06-28 | 9.73x |
| 2019-06-27 | 9.39x |
| 2019-06-26 | 9.05x |
| 2019-06-25 | 8.83x |
| 2019-06-24 | 8.80x |
| 2019-06-21 | 9.45x |
| 2019-06-20 | 10.26x |
| 2019-06-19 | 10.48x |
Showing the most recent 260 of 320 data points. The chart above shows the full history.
